<?xml version="1.0" encoding="UTF-8"?>
<ref id="B101-marinedrugs-18-00627">
 <label>101.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Curado Borges</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>de Miranda Moura dos Santos</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Weiss Telles</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Melo de Andrade</surname>
    <given-names>M.V.</given-names>
   </name>
   <name>
    <surname>Toulson Davisson Correia</surname>
    <given-names>M.I.</given-names>
   </name>
   <name>
    <surname>Lanna</surname>
    <given-names>C.C.D.</given-names>
   </name>
  </person-group>
  <article-title>Omega-3 Fatty Acids, Inflammatory Status and Biochemical Markers of Patients with Systemic Lupus Erythematosus: A Pilot Study</article-title>
  <source>Rev. Bras. Reumatol.</source>
  <year>2017</year>
  <volume>57</volume>
  <fpage>526</fpage>
  <lpage>534</lpage>
  <pub-id pub-id-type="doi">10.1016/j.rbre.2016.09.014</pub-id>
  <?supplied-pmid 29173690?>
  <pub-id pub-id-type="pmid">29173690</pub-id>
 </element-citation>
</ref>
